Thermo Fisher to Buy Back Stock | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Thursday that its board of directors has authorized the repurchase of up to $500 million of the firm’s common stock on the open market through Sept. 10, 2009.
 
The firm’s board had authorized a $1 billion share repurchase program from August 2007 to August 2008.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.